mRNA |
ML083 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
mRNA |
BRD-A71883111 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |
mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
-0.21 |
0.0005 |
mRNA |
SR1001 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
CHIR-99021 |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.004 |
mRNA |
BRD-K34099515 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
0.004 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.006 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.008 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.008 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.009 |